Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eusphera is an Italian biotechnology company specializing in the research, development, and production of high-quality nutraceuticals and cosmeceuticals derived from hemp and other natural sources. The company focuses on the therapeutic potential of cannabinoids, such as CBD and CBG, utilizing advanced extraction and purification technologies to ensure pharmaceutical-grade standards. Their product portfolio includes specialized supplements and topical treatments designed to address inflammation, pain management, and dermatological conditions. Eusphera maintains a strong commitment to scientific validation, frequently collaborating with academic institutions to conduct clinical studies on their formulations. By integrating green chemistry with biotechnological innovation, the company aims to provide effective, natural alternatives for health and wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eusphera.